CLINICAL_TRIALS
trial_result
· 2009-12-09
Clinical Trial Update: Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder [Phase 2]
Summary
This is an open-label Phase 2 clinical trial evaluating duloxetine for treating major depressive disorder in children and adolescents; the study has completed a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2009-12-09